SDZ-MKS 492
SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE) . SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF) -induced bronchoconstriction and allergic reactions in guinea pigs and rats[1].
Product Specifications
CAS Number
[114606-56-3]
Product Name Alternative
MKS 492
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sdz-mks-492.html
Purity
99.77
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(N1C)N(C)C2=C(N(CCOC)C(N[C@H](C3=CC=C(OC)C(OC)=C3)CO)=N2)C1=O
Molecular Formula
C20H27N5O6
Molecular Weight
433.46
References & Citations
[1]Nagai H, et al. Effects of MKS-492 on antigen-induced bronchoconstriction and allergic reaction in guinea pigs and rats. Jpn J Pharmacol. 1993 Dec;63 (4) :405-13.|[2]Morley J, et, al. SDZ MKS 492. Agents Actions Suppl. 1991;34:403-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
038387-ML490 100 µL
METTL2, CT (METTL2A, METTL2, Methyltransferase-like protein 2A) (MaxLight 490) discontinued
Ask
View Details 
MBS1099910-01 0.02 mg (E-Coli)
Recombinant Hirudo medicinalis Leech-derived tryptase inhibitor C
Ask
View Details MBS1099910-02 0.1 mg (E-Coli)
Recombinant Hirudo medicinalis Leech-derived tryptase inhibitor C
Ask
View Details MBS1099910-03 0.02 mg (Yeast)
Recombinant Hirudo medicinalis Leech-derived tryptase inhibitor C
Ask
View Details